2024 Q2 Form 10-Q Financial Statement

#000143612624000035 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $189.8M $184.4M
YoY Change 7.81% 9.78%
Cost Of Revenue $133.7M $133.4M
YoY Change 5.82% 9.36%
Gross Profit $56.12M $51.09M
YoY Change 12.86% 10.88%
Gross Profit Margin 29.57% 27.7%
Selling, General & Admin $40.96M $41.19M
YoY Change -1.27% -3.82%
% of Gross Profit 72.99% 80.62%
Research & Development $231.0K $343.0K
YoY Change -54.79% -28.54%
% of Gross Profit 0.41% 0.67%
Depreciation & Amortization $8.288M $2.447M
YoY Change -0.25% -70.91%
% of Gross Profit 14.77% 4.79%
Operating Expenses $41.19M $43.98M
YoY Change -1.92% 1.56%
Operating Profit $11.96M $7.111M
YoY Change 207.19% -488.58%
Interest Expense -$4.413M -$4.430M
YoY Change -214.39% -208.9%
% of Operating Profit -36.9% -62.3%
Other Income/Expense, Net
YoY Change
Pretax Income $7.546M $1.123M
YoY Change 21460.0% -119.04%
Income Tax $1.173M $119.0K
% Of Pretax Income 15.54% 10.6%
Net Earnings $6.369M $995.0K
YoY Change 1789.91% -119.96%
Net Earnings / Revenue 3.36% 0.54%
Basic Earnings Per Share $0.03
Diluted Earnings Per Share $0.20 $0.03
COMMON SHARES
Basic Shares Outstanding 30.97M shares 30.63M shares
Diluted Shares Outstanding 31.29M shares 31.36M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.18M $16.86M
YoY Change -4.57% 0.83%
Cash & Equivalents $17.18M $16.86M
Short-Term Investments
Other Short-Term Assets $11.38M $14.63M
YoY Change -36.72% 4.45%
Inventory $14.94M $15.08M
Prepaid Expenses
Receivables $150.0M $140.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $193.5M $187.0M
YoY Change 13.25% 12.69%
LONG-TERM ASSETS
Property, Plant & Equipment $78.79M $79.70M
YoY Change -3.09% 1.12%
Goodwill $185.0M $185.7M
YoY Change -8.23% -7.12%
Intangibles $41.71M $42.66M
YoY Change -9.61% -9.92%
Long-Term Investments
YoY Change
Other Assets $45.54M $47.07M
YoY Change 13.36% 22.42%
Total Long-Term Assets $354.7M $355.2M
YoY Change -4.17% -2.67%
TOTAL ASSETS
Total Short-Term Assets $193.5M $187.0M
Total Long-Term Assets $354.7M $355.2M
Total Assets $548.1M $542.1M
YoY Change 1.33% 2.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.76M $15.63M
YoY Change -19.13% 14.58%
Accrued Expenses $85.73M $84.48M
YoY Change 22.97% 24.47%
Deferred Revenue $8.296M $9.244M
YoY Change -10.38% -0.14%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.02M $14.37M
YoY Change 32.73% 94.94%
Total Short-Term Liabilities $114.5M $114.9M
YoY Change 4.41% 11.29%
LONG-TERM LIABILITIES
Long-Term Debt $189.7M $200.1M
YoY Change 7.71% 9.97%
Other Long-Term Liabilities $37.00M $36.98M
YoY Change 15.47% 21.53%
Total Long-Term Liabilities $226.7M $237.1M
YoY Change 8.9% 11.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.5M $114.9M
Total Long-Term Liabilities $226.7M $237.1M
Total Liabilities $354.7M $355.0M
YoY Change 4.19% 6.07%
SHAREHOLDERS EQUITY
Retained Earnings -$21.58M -$27.95M
YoY Change 33.71% 69.63%
Common Stock $385.0K $328.0K
YoY Change 27.48% 8.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $193.2M $187.1M
YoY Change
Total Liabilities & Shareholders Equity $548.1M $542.1M
YoY Change 1.33% 2.13%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $6.369M $995.0K
YoY Change 1789.91% -119.96%
Depreciation, Depletion And Amortization $8.288M $2.447M
YoY Change -0.25% -70.91%
Cash From Operating Activities $4.511M $604.0K
YoY Change -67.52% -86.37%
INVESTING ACTIVITIES
Capital Expenditures $6.082M $4.804M
YoY Change 2.56% 10.9%
Acquisitions
YoY Change
Other Investing Activities $513.0K $273.0K
YoY Change -11.4% 17.17%
Cash From Investing Activities -$5.569M -$5.648M
YoY Change 4.07% 26.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.907M
YoY Change 0.16%
Cash From Financing Activities 134.0K $5.127M
YoY Change -101.85% -229.76%
NET CHANGE
Cash From Operating Activities 4.511M $604.0K
Cash From Investing Activities -5.569M -$5.648M
Cash From Financing Activities 134.0K $5.127M
Net Change In Cash -924.0K -$791.0K
YoY Change -171.02% -79.02%
FREE CASH FLOW
Cash From Operating Activities $4.511M $604.0K
Capital Expenditures $6.082M $4.804M
Free Cash Flow -$1.571M -$4.200M
YoY Change -119.74% -4258.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30597633 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30597633 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1004000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
127418000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
116051000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
5934000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
5888000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
51090000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
46077000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41189000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42823000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
1557000 usd
CY2023Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2076000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
343000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
480000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2447000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2525000 usd
CY2024Q1 mg Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
1000 usd
CY2023Q1 mg Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
3000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5553000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1830000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4430000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4068000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1123000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5898000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
119000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-920000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1004000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4978000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4986000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30680000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30021000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31356000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30021000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1004000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4978000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4229000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1273000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3225000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3705000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3234000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3713000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
190503000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4229000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1228000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1041000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187465000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
198749000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1273000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1877000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-773000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1004000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4978000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8381000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8413000 usd
CY2024Q1 mg Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
144000 usd
CY2023Q1 mg Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-1801000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1228000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1877000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
227000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-30000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
561000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-219000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
315000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8696000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3777000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1137000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6593000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4234000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1219000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
992000 usd
CY2024Q1 mg Increase Decrease In Other Accrued Liabilities And Deferred Liabilities
IncreaseDecreaseInOtherAccruedLiabilitiesAndDeferredLiabilities
6905000 usd
CY2023Q1 mg Increase Decrease In Other Accrued Liabilities And Deferred Liabilities
IncreaseDecreaseInOtherAccruedLiabilitiesAndDeferredLiabilities
-766000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
80000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-248000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
938000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
604000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4433000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4804000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4332000 usd
CY2024Q1 mg Payments To Acquire Intangible Assets And Software
PaymentsToAcquireIntangibleAssetsAndSoftware
1117000 usd
CY2023Q1 mg Payments To Acquire Intangible Assets And Software
PaymentsToAcquireIntangibleAssetsAndSoftware
361000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
273000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
233000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5648000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4460000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1409000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1174000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1907000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1904000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
27000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
27100000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1557000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
773000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5127000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3951000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-874000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
207000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-791000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3771000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17646000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20488000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16855000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16717000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
4029000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
5112000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
756000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1949000 usd
CY2024Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1165000 usd
CY2023Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2800000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30021000 shares
CY2024Q1 mg Incremental Common Shares Attributable To Stock Options Outstanding
IncrementalCommonSharesAttributableToStockOptionsOutstanding
250000 shares
CY2023Q1 mg Incremental Common Shares Attributable To Stock Options Outstanding
IncrementalCommonSharesAttributableToStockOptionsOutstanding
0 shares
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior periods have been reclassified to conform to the current year presentation. Such reclassifications did not have a material effect on the Company's financial condition or results of operations as previously reported.</span></div>
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.106
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.156
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184442000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168016000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184442000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168016000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2900000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3100000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.36
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.36
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4986000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30680000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30021000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4986000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30680000 shares
CY2024Q1 mg Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
426000 shares
CY2023Q1 mg Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31356000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30021000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2024Q1 mg Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
1000 usd
CY2023Q1 mg Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
3000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
142245000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
134495000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1841000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1648000 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
140404000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
132847000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
36500000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
18500000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5974000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6099000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1003000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
839000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5495000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5740000 usd
CY2024Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2607000 usd
CY2023Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2605000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
15079000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
15283000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
321384000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
319756000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
241682000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
238784000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
79702000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
80972000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
6500000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
6300000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
187354000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1628000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
185726000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
187815000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
145155000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42660000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
188835000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
144841000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43994000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 usd
CY2024Q1 mg Accrued Salaries Wages And Employee Related Benefits Current
AccruedSalariesWagesAndEmployeeRelatedBenefitsCurrent
28373000 usd
CY2023Q4 mg Accrued Salaries Wages And Employee Related Benefits Current
AccruedSalariesWagesAndEmployeeRelatedBenefitsCurrent
27372000 usd
CY2024Q1 mg Accrued Workers Compensation And Health Benefits Current
AccruedWorkersCompensationAndHealthBenefitsCurrent
3590000 usd
CY2023Q4 mg Accrued Workers Compensation And Health Benefits Current
AccruedWorkersCompensationAndHealthBenefitsCurrent
4385000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9244000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7136000 usd
CY2024Q1 us-gaap Multiemployer Plans Withdrawal Obligation
MultiemployerPlansWithdrawalObligation
2458000 usd
CY2023Q4 us-gaap Multiemployer Plans Withdrawal Obligation
MultiemployerPlansWithdrawalObligation
2458000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10743000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10686000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30067000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32294000 usd
CY2024Q1 mg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
84475000 usd
CY2023Q4 mg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
84331000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
198426000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
190399000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
9464000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8900000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
188962000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
181499000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184442000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168016000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
51090000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
46077000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5553000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1830000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8381000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8413000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42660000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43994000 usd
CY2024Q1 us-gaap Assets
Assets
542127000 usd
CY2023Q4 us-gaap Assets
Assets
534776000 usd

Files In Submission

Name View Source Status
0001436126-24-000035-index-headers.html Edgar Link pending
0001436126-24-000035-index.html Edgar Link pending
0001436126-24-000035.txt Edgar Link pending
0001436126-24-000035-xbrl.zip Edgar Link pending
a10qexhibit311-q12024.htm Edgar Link pending
a10qexhibit312-q12024.htm Edgar Link pending
a10qexhibit321-q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hanihammadagreement.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mg-20240331.htm Edgar Link pending
mg-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
mg-20240331_cal.xml Edgar Link unprocessable
mg-20240331_def.xml Edgar Link unprocessable
mg-20240331_lab.xml Edgar Link unprocessable
mg-20240331_pre.xml Edgar Link unprocessable
mg-20240331_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable